PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹3,393 Cr | ₹2,645 Cr | ₹3,812 Cr | ₹2,903 Cr | ₹2,560 Cr |
What is the latest Total Non-Current Liabilities ratio of PIRAMAL PHARMA ?
Year | Total Non-Current Liabilities |
---|---|
Mar2025 | ₹3,393 Cr |
Mar2024 | ₹2,645 Cr |
Mar2023 | ₹3,812 Cr |
Mar2022 | ₹2,903 Cr |
Mar2021 | ₹2,560 Cr |
How is Total Non-Current Liabilities of PIRAMAL PHARMA Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹3,393 Cr | 28.29 | |
Mar2024 | ₹2,645 Cr | -30.62 | |
Mar2023 | ₹3,812 Cr | 31.33 | |
Mar2022 | ₹2,903 Cr | 13.37 | |
Mar2021 | ₹2,560 Cr | - |
Compare Total Non-Current Liabilities of peers of PIRAMAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PIRAMAL PHARMA | ₹24,404.1 Cr | -4.7% | -10.7% | 0.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,466.0 Cr | -3% | -6.8% | -11.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,423.0 Cr | -0.5% | -8.4% | 25.1% | Stock Analytics | |
CIPLA | ₹128,405.0 Cr | -0.2% | 1% | -1.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,448.0 Cr | -3.4% | -5.6% | 6.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,411.0 Cr | -1.1% | -2.9% | -9.5% | Stock Analytics |
PIRAMAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PIRAMAL PHARMA | -4.7% |
-10.7% |
0.8% |
SENSEX | -2.7% |
-1.3% |
-2.3% |
You may also like the below Video Courses